Dan-Xia Zhu
Overview
Explore the profile of Dan-Xia Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui M, Yi X, Zhu D, Wu J
Curr Oncol
. 2023 Jan;
30(1):1-18.
PMID: 36661650
Purpose: In recent years, lipid metabolism has been reprogrammed to meet the energy and substrate needs of tumorigenesis and development and is a potential new target for cancer treatment. However,...
2.
Cui M, Yi X, Cao Z, Zhu D, Wu J
J Oncol
. 2022 Sep;
2022:4257359.
PMID: 36106333
Esophageal cancer is of high importance to occurrence, development, and treatment resistance. As evidenced by recent studies, pathways (e.g., Wnt/-catenin, AMPK, and Hippo) are critical to the proliferation, differentiation, and...
3.
Cui M, Yi X, Zhu D, Wu J
Front Oncol
. 2022 Jul;
12:916661.
PMID: 35785165
Gastric cancer has been one of the most common cancers worldwide with extensive metastasis and high mortality. Chemotherapy has been found as a main treatment for metastatic gastric cancer, whereas...
4.
Cui M, Yi X, Zhu D, Wu J
Transl Cancer Res
. 2022 Feb;
10(8):3829-3842.
PMID: 35116681
Objective: We summarize the aberrant lipid metabolism disorders associated with enzyme activity and expression changes and related immune microenvironment for gastric cancer. Background: Gastric cancer is a malignant tumor of...
5.
Xian Q, Li X, Zhang H, Wu J, Zhu D
Int J Clin Exp Pathol
. 2021 Jan;
13(12):3181-3186.
PMID: 33425119
A 61-year-old male patient was admitted to our hospital with frequent urination, urgency, and increased nocturia for more than 3 months, and the symptoms were aggravated for 1 week. Prostate...
6.
Shan X, Zhang L, Zhu D, Zhou X, Zhang H, Liu Q, et al.
Chin Med J (Engl)
. 2020 Sep;
133(21):2532-2542.
PMID: 32947363
Background: Recent studies have demonstrated that microRNAs (miRNAs) in the blood circulation can serve as promising diagnostic markers for cancers. This four-stage study aimed at finding serum miRNAs as potential...
7.
He B, Zhu D, Chao H
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Aug;
26(4):1111-1115.
PMID: 30111416
Objective: To investigate the expression and function of miR-181b in diffuse large B cell lymphoma (DLBCL). Methods: The lymphoid tissues of 124 patients with DLBCL examined and treated in our...
8.
Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population
Fang C, Zhu D, Wang L, Fan L, Xu J, Wu J, et al.
Int J Clin Exp Med
. 2015 Sep;
8(7):11235-43.
PMID: 26379930
Rituximab was widely used in clinical practice. Some chronic lymphocytic leukemia (CLL) patients were primary or secondary resistance to rituximab, but the mechanism has not been yet clear. CD20 gene...
9.
Dai J, Zhu D, Sheng J, Chen X, Li W, Wang G, et al.
Molecules
. 2015 Apr;
20(4):6794-807.
PMID: 25884554
Salvia miltiorrhiza Bunge has been reported to possess excellent antifibrotic activity. In this study, we have investigated the effect and mechanism of tanshinone IIA (Tan-IIA), salvianolic acid A (Sal-A) and...
10.
Dai J, Chen X, Zhu D, Wan Q, Chen C, Wang G, et al.
J Oral Pathol Med
. 2014 Feb;
43(6):464-70.
PMID: 24484214
Background: Oral submucous fibrosis (OSF) is a premalignant and fibrosing disease, which is closely associated with the habit of chewing areca nut. Panax notoginseng Buck F. H. Chen is an...